Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost
about
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin ResistanceFirst report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721.The fosfomycin resistance gene fosB3 is located on a transferable, extrachromosomal circular intermediate in clinical Enterococcus faecium isolates.Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in TaiwanEscherichia coli ASKA Clone Library Harboring tRNA-Specific Adenosine Deaminase (tadA) Reveals Resistance towards Xanthorrhizol.Indirect resistance to several classes of antibiotics in cocultures with resistant bacteria expressing antibiotic-modifying or -degrading enzymes.Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.Yeast: a microbe with macro-implications to antimicrobial drug discovery.Fosfomycin: Mechanism and Resistance.Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.Computed insight into a peptide inhibitor preventing the induced fit mechanism of MurA enzyme from Pseudomonas aeruginosa.Parallel Evolution of High-Level Aminoglycoside Resistance in Escherichia coli Under Low and High Mutation Supply Rates.
P2860
Q26853135-1682D31D-306B-4A6B-9E08-3397DF645493Q34922505-5AA2C330-7D10-4CCE-85A9-C8240D4A4226Q35036048-3E72D7FE-5971-415B-8B96-D4BD3643E657Q35747796-2EB79CD9-3F2C-4977-843E-897DB95489EDQ35775522-73AF3020-1BE4-4548-A272-596FD1F32605Q35807773-56D798C1-3108-4D7A-9F37-E6860ADE400AQ37263313-AC616A3A-FF74-4E51-82FE-3471AAE409F2Q38601083-D43883F9-8DBD-4146-885F-F79B317B54CAQ39071416-9CA375DB-8E26-405E-9679-373A0DC51DACQ48179364-0384FB67-624E-45E5-9D18-1DAFAC1960D4Q51773259-A05E1771-F17F-4B81-A845-F0D6FDA4F112Q54242442-F02EBB5F-2E2D-4E8C-836F-089A9D24C9DB
P2860
Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genomewide overexpression scre ...... resistance at low fitness cost
@ast
Genomewide overexpression scre ...... resistance at low fitness cost
@en
type
label
Genomewide overexpression scre ...... resistance at low fitness cost
@ast
Genomewide overexpression scre ...... resistance at low fitness cost
@en
prefLabel
Genomewide overexpression scre ...... resistance at low fitness cost
@ast
Genomewide overexpression scre ...... resistance at low fitness cost
@en
P2093
P2860
P356
P1476
Genomewide overexpression scre ...... resistance at low fitness cost
@en
P2093
Alejandra Briales
Alejandro Couce
Alexandro Rodríguez-Rojas
Alvaro Pascual
Coloma Costas
Jesús Blázquez
P2860
P304
P356
10.1128/AAC.06122-11
P407
P577
2012-02-27T00:00:00Z